Kåvepenin Filmuhúðuð tafla 500 mg Iceland - Iceland - LYFJASTOFNUN (Icelandic Medicines Agency)

kåvepenin filmuhúðuð tafla 500 mg

viatris aps - phenoxymethylpenicillinum kalíum - filmuhúðuð tafla - 500 mg

Kåvepenin Filmuhúðuð tafla 800 mg Iceland - Iceland - LYFJASTOFNUN (Icelandic Medicines Agency)

kåvepenin filmuhúðuð tafla 800 mg

viatris aps - phenoxymethylpenicillinum kalíum - filmuhúðuð tafla - 800 mg

Kåvepenin Mixtúrukyrni, dreifa 100 mg/ml Iceland - Iceland - LYFJASTOFNUN (Icelandic Medicines Agency)

kåvepenin mixtúrukyrni, dreifa 100 mg/ml

viatris aps - phenoxymethylpenicillinum kalíum - mixtúrukyrni, dreifa - 100 mg/ml

Kåvepenin Frukt (Kåvepenin (mixt. 50 mg/ml)) Mixtúrukyrni, dreifa 50 mg/ml Iceland - Iceland - LYFJASTOFNUN (Icelandic Medicines Agency)

kåvepenin frukt (kåvepenin (mixt. 50 mg/ml)) mixtúrukyrni, dreifa 50 mg/ml

viatris aps - phenoxymethylpenicillinum kalíum - mixtúrukyrni, dreifa - 50 mg/ml

Ceftriaxon Fresenius Kabi Innrennslisstofn, lausn 2 g Iceland - Iceland - LYFJASTOFNUN (Icelandic Medicines Agency)

ceftriaxon fresenius kabi innrennslisstofn, lausn 2 g

fresenius kabi ab - ceftriaxonum dínatríum - innrennslisstofn, lausn - 2 g

Ceftriaxon Fresenius Kabi Stungulyfs-/innrennslisstofn, lausn 1 g Iceland - Iceland - LYFJASTOFNUN (Icelandic Medicines Agency)

ceftriaxon fresenius kabi stungulyfs-/innrennslisstofn, lausn 1 g

fresenius kabi ab - ceftriaxonum dínatríum - stungulyfs-/innrennslisstofn, lausn - 1 g

Jardiance Kesatuan Eropah - Iceland - EMA (European Medicines Agency)

jardiance

boehringer ingelheim international gmbh - empagliflozin - diabetes mellitus, type 2; heart failure; renal insufficiency, chronic - lyf notuð við sykursýki - type 2 diabetes mellitusjardiance is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exerciseas monotherapy when metformin is considered in addition to other medicinal products for the treatment of diabetesfor study results with respect to combinations of therapies, effects on glycaemic control, and cardiovascular and renal events, and the populations studied, see sections 4. 4, 4. 5 og 5. of the annex. heart failurejardiance is indicated in adults for the treatment of symptomatic chronic heart failure.  chronic kidney diseasejardiance is indicated in adults for the treatment of chronic kidney disease.

Abilify Maintena Kesatuan Eropah - Iceland - EMA (European Medicines Agency)

abilify maintena

otsuka pharmaceutical netherlands b.v. - aripíprazól - geðklofa - psycholeptics - viðhald meðferð geðklofa í fullorðinn sjúklingar stöðug með inntöku sjúklingum.

Nulojix Kesatuan Eropah - Iceland - EMA (European Medicines Agency)

nulojix

bristol-myers squibb pharma eeig - belatacept - graft rejection; kidney transplantation - Ónæmisbælandi lyf - nulojix, in combination with corticosteroids and a mycophenolic acid (mpa), is indicated for prophylaxis of graft rejection in adult recipients of a renal transplant.

Forxiga Kesatuan Eropah - Iceland - EMA (European Medicines Agency)

forxiga

astrazeneca ab - dapagliflozin própandiolól einhýdrat - diabetes mellitus, type 2; heart failure, systolic; heart failure; renal insufficiency, chronic - lyf notuð við sykursýki - type 2 diabetes mellitusforxiga is indicated in adults and children aged 10 years and above for the treatment of insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exerciseas monotherapy when metformin is considered inappropriate due to intolerance. auk þess önnur lyf fyrir meðferð tegund sykursýki 2. for study results with respect to combination of therapies, effects on glycaemic control, cardiovascular and renal events, and the populations studied, see sections 4. 4, 4. 5 og 5. heart failureforxiga is indicated in adults for the treatment of symptomatic chronic heart failure. chronic kidney diseaseforxiga is indicated in adults for the treatment of chronic kidney disease.